4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000076
Chief Financial Officer sold 2,993 shares at $14.89 ($44,566)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barnett Eva Renee Chief Financial Officer | 2025-04-16 | Sale | −2,993 | $14.89 | $44,566 | 396,774 | D |
| Open-market sales · 2,993 sh · avg $14.89 · $44,566 | |||||||
Loading xslF345X05/wk-form4_1744920500.xml…